CNTN2

Chr 1AR

contactin 2

Also known as: AXT, EPEO5, FAME5, TAG-1, TAX, TAX1

This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.441 OMIM phenotype
Clinical SummaryCNTN2
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.29) despite low pLI — interpret in context.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 228 VUS of 584 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.44LOEUF
pLI 0.002
Z-score 4.92
OE 0.29 (0.190.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.59Z-score
OE missense 0.72 (0.670.78)
481 obs / 669.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.29 (0.190.44)
00.351.4
Missense OE?0.72 (0.670.78)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 16 / 55.6Missense obs/exp: 481 / 669.4Syn Z: 1.02

This gene — mechanism propensity

DN
0.76top 25%
GOF
0.6639th %ile
LOF
0.3550th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative, gain-of-function and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median
LOF94% of P/LP variants are LoF · LOEUF 0.44

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

584 submitted variants in ClinVar

Classification Summary

Pathogenic20
Likely Pathogenic13
VUS228
Likely Benign286
Benign17
Conflicting16
20
Pathogenic
13
Likely Pathogenic
228
VUS
286
Likely Benign
17
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
19
0
1
0
20
Likely Pathogenic
12
0
1
0
13
VUS
1
211
13
3
228
Likely Benign
0
9
106
171
286
Benign
0
5
2
10
17
Conflicting
16
Total32225123184580

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

15 pathogenic / likely-pathogenic (of 24) ClinVar copy-number / structural variants overlap CNTN2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CNTN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →